These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14664288)

  • 21. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study.
    Lancet; 1997 May; 349(9063):1429-35. PubMed ID: 9164316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does abciximab provide long-term benefit for patients with acute myocardial infarction treated with stents?
    Neumann FJ
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):190-1. PubMed ID: 16568126
    [No Abstract]   [Full Text] [Related]  

  • 23. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Profound thrombocytopenia after abciximab administration in acute myocardial infarction and stent thrombosis following thrombocytopenia remission--a case report].
    Elikowski W; Rzeźniczak J; Słomczyński M; Psuja P
    Kardiol Pol; 2005 Jan; 62(1):44-7; discussion 48. PubMed ID: 15815778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of monorail PTCA balloon catheter for local drug delivery.
    Trehan V; Nair GM; Gupta MD
    J Invasive Cardiol; 2007 Jan; 19(1):E23-6. PubMed ID: 17297192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial.
    Marmur JD; Mitre CA; Barnathan E; Cavusoglu E
    Am Heart J; 2006 Nov; 152(5):876-81. PubMed ID: 17070148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between glycoprotein IIb/IIIa blockade and distal protection device for the restoration of myocardial perfusion during percutaneous coronary intervention for acute myocardial infarction.
    Mak KH; Phay C; Wong A; Kwok V; Tan KS; Lau KW; Koh TH
    J Invasive Cardiol; 2004 Dec; 16(12):694-8. PubMed ID: 15596872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How should I treat a patient with a proximal left anterior descending large plaque burden embolising plaque?
    Moretti C; Perversi J; Omedè P; D'Ascenzo F; Bergerone S; Gaita F; Sabaté M; Shan SJ; Zhang JJ; Chen SL
    EuroIntervention; 2015 Oct; 11(6):723-6. PubMed ID: 26499225
    [No Abstract]   [Full Text] [Related]  

  • 29. Coronary artery stenting during acute myocardial infarction in patients treated with IIb/IIIa anti-platelet antibodies: early outcome results.
    Murdock DK; Hoffman MT; Logemann TN; Kaufman JS; Engelmeier RS
    Wis Med J; 1996 Dec; 95(12):867-71. PubMed ID: 8993226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right atrial thrombus treated successfully with abciximab and heparin.
    Borges AC; Reibis RK; Claus M; Baumann G
    J Thromb Thrombolysis; 2001 Dec; 12(3):283-7. PubMed ID: 11981111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful dissolution of occlusive coronary thrombus with local administration of abciximab during PTCA.
    Bartorelli AL; Trabattoni D; Galli S; Grancini L; Cozzi S; Ravagnani P
    Catheter Cardiovasc Interv; 1999 Oct; 48(2):211-3. PubMed ID: 10506783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distal protection of the left anterior desceding artery with the EX Filter Wire during an acute coronary syndrome.
    Pershad A; Stevenson J
    J Invasive Cardiol; 2004 Nov; 16(11):665-6. PubMed ID: 15550743
    [No Abstract]   [Full Text] [Related]  

  • 33. Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions.
    Kleiman NS; Grazeiadei N; Maresh K; Taylor RJ; Frederick B; Lance ET; Effron MB; Jordan RE; Mascelli MA
    Am Heart J; 2000 Sep; 140(3):492-501. PubMed ID: 10966553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Off-pump" repair of a postangioplasty coronary artery bleed.
    Devey LR; Shaw TR; Zamvar V
    J Card Surg; 2005; 20(3):281-3. PubMed ID: 15854096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different benefits, different risks, equal cost.
    Colombo A
    Eur Heart J; 1999 Nov; 20(21):1531-2. PubMed ID: 10529320
    [No Abstract]   [Full Text] [Related]  

  • 36. Abciximab: a review and update for clinicians.
    Mazzaferri EL; Young JJ
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):609-18. PubMed ID: 18510478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of abciximab prevents microcirculatory impairment in patients treated with coronary angioplasty for unstable angina: results of a prospective randomized study.
    Prati F; Kwiatkowski P; Caroselli C; Imola F; Manzoli A; Fouad T; Corvo P; Ramazzotti V
    Catheter Cardiovasc Interv; 2005 Oct; 66(2):165-9. PubMed ID: 16142802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bleeding complications of platelet glycoprotein IIb/IIIa inhibitor abciximab (ReoPro ).
    Trivedi SM; Shani J; Hollander G
    J Invasive Cardiol; 2002 Jul; 14(7):423-5. PubMed ID: 12082199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abciximab offers greater benefits to insulin-dependent diabetic patients undergoing coronary stent implantation.
    López-Mínguez JR; Nogales JM; González R; Palanco C; Doncel J; Vaello A; Giménez F; Morales A; Alonso R; Merchán A
    Cardiovasc Revasc Med; 2007; 8(3):175-82. PubMed ID: 17765647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic impact of same-day home discharge after uncomplicated transradial percutaneous coronary intervention and bolus-only abciximab regimen.
    Rinfret S; Kennedy WA; Lachaine J; Lemay A; Rodés-Cabau J; Cohen DJ; Costerousse O; Bertrand OF
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1011-9. PubMed ID: 20965458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.